Atupan, Emelyn G.

HRN: 22-81-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2023
CEFUROXIME 1.5GM (VIAL)
04/01/2023
04/01/2023
IV
1.5
Q8 X 2 More Dose + Replacement
S/P Primary LSTCS
Waiting Final Action 
04/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/01/2023
04/01/2023
IV
500mg
Q8 X 2 More Doses + Replacement
S/P Primary LSTCS
Waiting Final Action 
04/02/2023
CEFUROXIME 500MG (TAB)
04/02/2023
04/09/2023
ORAL
500mg
BID
S/P NSVD, Uti
Waiting Final Action 
04/02/2023
METRONIDAZOLE 500MG (TAB)
04/02/2023
04/08/2023
PO
500mg
TID
S/P CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: